ID

21434

Beschrijving

Study of Dasatinib in Patients With Chronic Phase Chronic Myeloid Leukemia and a Suboptimal Response to Imatinib; ODM derived from: https://clinicaltrials.gov/show/NCT00320190

Link

https://clinicaltrials.gov/show/NCT00320190

Trefwoorden

Versies (1)
  1. 21-04-17 21-04-17 -
Geüploaded op

21 april 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Leukemia, Myeloid, Chronic NCT00320190

Engels

Eligibility Leukemia, Myeloid, Chronic NCT00320190

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
chronic phase ph^+ chronic myeloid leukemia (cml) demonstrating only a suboptimal response, defined as a hematologic response that is less than a complete hematologic response after at least 3 months of monotherapy with imatinib, 400 mg; a cytogenic response (cgr) that is less than a partial cgr (pcgr) after at least 6 months of monotherapy with imatinib, 400 mg; a pcgr after at least 12 months of monotherapy with imatinib, 400 mg; or less than a major molecular response with a complete cgr after at least 18 months of monotherapy with imatinib, 400 mg.
Beschrijving

Philadelphia chromosome positive chronic myelogenous leukemia Chronic phase | Response Suboptimal | imatinib Dosage | Hematologic Response Less Than Complete Hematologic Response | Cytogenetic Response Less Than Cytogenetic Partial Response | Cytogenetic Partial Response | Cytogenetic Response Less Than Molecular Major Response | Cytogenetic Complete Response

Datatype

boolean

Alias
UMLS CUI [1,1]
C0279543
UMLS CUI [1,2]
C0457343
UMLS CUI [2,1]
C1704632
UMLS CUI [2,2]
C2984009
UMLS CUI [3,1]
C0935989
UMLS CUI [3,2]
C0178602
UMLS CUI [4,1]
C4054793
UMLS CUI [4,2]
C0439092
UMLS CUI [4,3]
C4050175
UMLS CUI [5,1]
C4055168
UMLS CUI [5,2]
C0439092
UMLS CUI [5,3]
C4055169
UMLS CUI [6]
C4055169
UMLS CUI [7,1]
C4055168
UMLS CUI [7,2]
C0439092
UMLS CUI [7,3]
C4049637
UMLS CUI [8]
C4050364
either gender
Beschrijving

Gender Both

Datatype

boolean

Alias
UMLS CUI [1,1]
C0079399
UMLS CUI [1,2]
C1706086
age of 18 years or older
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous diagnosis of accelerated phase or blast crisis cml
Beschrijving

Accelerated phase chronic myologenic leukemia | Leukemia, blastic crisis (CML)

Datatype

boolean

Alias
UMLS CUI [1]
C0919870
UMLS CUI [2]
C0687162
uncontrolled or significant cardiovascular disease
Beschrijving

Cardiovascular Disease Uncontrolled | Cardiovascular Disease Significant

Datatype

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0007222
UMLS CUI [2,2]
C0750502
history of significant bleeding disorder unrelated to cml
Beschrijving

Blood Coagulation Disorder | CML Relationship Absent

Datatype

boolean

Alias
UMLS CUI [1]
C0005779
UMLS CUI [2,1]
C0023473
UMLS CUI [2,2]
C0439849
UMLS CUI [2,3]
C0332197
concurrent malignancies
Beschrijving

Malignant Neoplasms

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
intolerance of imatinib, 400 mg
Beschrijving

intolerance to imatinib Dosage

Datatype

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C0935989
UMLS CUI [1,3]
C0178602
prior treatment with imatinib at a dose higher than 400 mg
Beschrijving

imatinib Dosage

Datatype

boolean

Alias
UMLS CUI [1,1]
C0935989
UMLS CUI [1,2]
C0178602
prior stem cell transplantation and/or high-dose chemotherapy for cml
Beschrijving

Stem cell transplant CML | HIGH DOSE CHEMOTHEARPY CML

Datatype

boolean

Alias
UMLS CUI [1,1]
C1504389
UMLS CUI [1,2]
C0023473
UMLS CUI [2,1]
C0149710
UMLS CUI [2,2]
C0023473
Terug naar het begin van de pagina

Similar models

Eligibility Leukemia, Myeloid, Chronic NCT00320190

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Philadelphia chromosome positive chronic myelogenous leukemia Chronic phase | Response Suboptimal | imatinib Dosage | Hematologic Response Less Than Complete Hematologic Response | Cytogenetic Response Less Than Cytogenetic Partial Response | Cytogenetic Partial Response | Cytogenetic Response Less Than Molecular Major Response | Cytogenetic Complete Response
Item
chronic phase ph^+ chronic myeloid leukemia (cml) demonstrating only a suboptimal response, defined as a hematologic response that is less than a complete hematologic response after at least 3 months of monotherapy with imatinib, 400 mg; a cytogenic response (cgr) that is less than a partial cgr (pcgr) after at least 6 months of monotherapy with imatinib, 400 mg; a pcgr after at least 12 months of monotherapy with imatinib, 400 mg; or less than a major molecular response with a complete cgr after at least 18 months of monotherapy with imatinib, 400 mg.
boolean
C0279543 (UMLS CUI [1,1])
C0457343 (UMLS CUI [1,2])
C1704632 (UMLS CUI [2,1])
C2984009 (UMLS CUI [2,2])
C0935989 (UMLS CUI [3,1])
C0178602 (UMLS CUI [3,2])
C4054793 (UMLS CUI [4,1])
C0439092 (UMLS CUI [4,2])
C4050175 (UMLS CUI [4,3])
C4055168 (UMLS CUI [5,1])
C0439092 (UMLS CUI [5,2])
C4055169 (UMLS CUI [5,3])
C4055169 (UMLS CUI [6])
C4055168 (UMLS CUI [7,1])
C0439092 (UMLS CUI [7,2])
C4049637 (UMLS CUI [7,3])
C4050364 (UMLS CUI [8])
Gender Both
Item
either gender
boolean
C0079399 (UMLS CUI [1,1])
C1706086 (UMLS CUI [1,2])
Age
Item
age of 18 years or older
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Accelerated phase chronic myologenic leukemia | Leukemia, blastic crisis (CML)
Item
previous diagnosis of accelerated phase or blast crisis cml
boolean
C0919870 (UMLS CUI [1])
C0687162 (UMLS CUI [2])
Cardiovascular Disease Uncontrolled | Cardiovascular Disease Significant
Item
uncontrolled or significant cardiovascular disease
boolean
C0007222 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0007222 (UMLS CUI [2,1])
C0750502 (UMLS CUI [2,2])
Blood Coagulation Disorder | CML Relationship Absent
Item
history of significant bleeding disorder unrelated to cml
boolean
C0005779 (UMLS CUI [1])
C0023473 (UMLS CUI [2,1])
C0439849 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Malignant Neoplasms
Item
concurrent malignancies
boolean
C0006826 (UMLS CUI [1])
intolerance to imatinib Dosage
Item
intolerance of imatinib, 400 mg
boolean
C1744706 (UMLS CUI [1,1])
C0935989 (UMLS CUI [1,2])
C0178602 (UMLS CUI [1,3])
imatinib Dosage
Item
prior treatment with imatinib at a dose higher than 400 mg
boolean
C0935989 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
Stem cell transplant CML | HIGH DOSE CHEMOTHEARPY CML
Item
prior stem cell transplantation and/or high-dose chemotherapy for cml
boolean
C1504389 (UMLS CUI [1,1])
C0023473 (UMLS CUI [1,2])
C0149710 (UMLS CUI [2,1])
C0023473 (UMLS CUI [2,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial